Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03646123
Title Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Age Groups: adult | child | senior
Covered Countries USA | ITA | ESP | AUS

No variant requirements are available.